These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 16123806

  • 1. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L, Bianco C, Normanno N, Salomon D.
    Oncogene; 2005 Aug 29; 24(37):5731-41. PubMed ID: 16123806
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo.
    Liguori GL, Borges AC, D'Andrea D, Liguoro A, Gonçalves L, Salgueiro AM, Persico MG, Belo JA.
    Dev Biol; 2008 Mar 15; 315(2):280-9. PubMed ID: 18241853
    [Abstract] [Full Text] [Related]

  • 4. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB, Bianco C, Schiffer SG, Rayhorn P, Zafari M, Cheung AE, Orozco O, Olson D, De Luca A, Chen LL, Miatkowski K, Benjamin C, Normanno N, Williams KP, Jarpe M, LePage D, Salomon D, Sanicola M.
    J Clin Invest; 2003 Aug 15; 112(4):575-87. PubMed ID: 12925698
    [Abstract] [Full Text] [Related]

  • 5. Non-cell-autonomous role for Cripto in axial midline formation during vertebrate embryogenesis.
    Chu J, Ding J, Jeays-Ward K, Price SM, Placzek M, Shen MM.
    Development; 2005 Dec 15; 132(24):5539-51. PubMed ID: 16291788
    [Abstract] [Full Text] [Related]

  • 6. Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.
    Normanno N, De Luca A, Bianco C, Maiello MR, Carriero MV, Rehman A, Wechselberger C, Arra C, Strizzi L, Sanicola M, Salomon DS.
    J Cell Physiol; 2004 Jan 15; 198(1):31-9. PubMed ID: 14584041
    [Abstract] [Full Text] [Related]

  • 7. Cell-type specific regulation of myostatin signaling.
    Kemaladewi DU, de Gorter DJ, Aartsma-Rus A, van Ommen GJ, ten Dijke P, 't Hoen PA, Hoogaars WM.
    FASEB J; 2012 Apr 15; 26(4):1462-72. PubMed ID: 22202673
    [Abstract] [Full Text] [Related]

  • 8. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
    Gray PC, Harrison CA, Vale W.
    Proc Natl Acad Sci U S A; 2003 Apr 29; 100(9):5193-8. PubMed ID: 12682303
    [Abstract] [Full Text] [Related]

  • 9. Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.
    Kenney NJ, Adkins HB, Sanicola M.
    J Mammary Gland Biol Neoplasia; 2004 Apr 29; 9(2):133-44. PubMed ID: 15300009
    [Abstract] [Full Text] [Related]

  • 10. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
    Bianco C, Adkins HB, Wechselberger C, Seno M, Normanno N, De Luca A, Sun Y, Khan N, Kenney N, Ebert A, Williams KP, Sanicola M, Salomon DS.
    Mol Cell Biol; 2002 Apr 29; 22(8):2586-97. PubMed ID: 11909953
    [Abstract] [Full Text] [Related]

  • 11. Nodal-dependant Cripto signaling in ES cells: from stem cells to tumor biology.
    Minchiotti G.
    Oncogene; 2005 Aug 29; 24(37):5668-75. PubMed ID: 16123800
    [Abstract] [Full Text] [Related]

  • 12. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms.
    Yeo C, Whitman M.
    Mol Cell; 2001 May 29; 7(5):949-57. PubMed ID: 11389842
    [Abstract] [Full Text] [Related]

  • 13. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis.
    Shukla A, Ho Y, Liu X, Ryscavage A, Glick AB.
    Mol Cancer Res; 2008 Mar 29; 6(3):509-16. PubMed ID: 18337457
    [Abstract] [Full Text] [Related]

  • 14. An evolving web of signaling networks regulated by Cripto-1.
    Nagaoka T, Karasawa H, Castro NP, Rangel MC, Salomon DS, Bianco C.
    Growth Factors; 2012 Feb 29; 30(1):13-21. PubMed ID: 22149969
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y, Strizzi L, Raafat A, Hirota M, Bianco C, Feigenbaum L, Kenney N, Wechselberger C, Callahan R, Salomon DS.
    Am J Pathol; 2005 Aug 29; 167(2):585-97. PubMed ID: 16049342
    [Abstract] [Full Text] [Related]

  • 16. Cripto localizes Nodal at the limiting membrane of early endosomes.
    Blanchet MH, Le Good JA, Oorschot V, Baflast S, Minchiotti G, Klumperman J, Constam DB.
    Sci Signal; 2008 Nov 11; 1(45):ra13. PubMed ID: 19001664
    [Abstract] [Full Text] [Related]

  • 17. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
    Gray PC, Shani G, Aung K, Kelber J, Vale W.
    Mol Cell Biol; 2006 Dec 11; 26(24):9268-78. PubMed ID: 17030617
    [Abstract] [Full Text] [Related]

  • 18. Cripto monoclonal antibodies.
    Hu XF, Xing PX.
    Drug News Perspect; 2005 Jun 11; 18(5):293-303. PubMed ID: 16193101
    [Abstract] [Full Text] [Related]

  • 19. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S, D'Andrea D, Lago CT, Adamson ED, Persico MG, Minchiotti G.
    J Cell Biol; 2003 Oct 27; 163(2):303-14. PubMed ID: 14581455
    [Abstract] [Full Text] [Related]

  • 20. The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.
    Klauzinska M, Castro NP, Rangel MC, Spike BT, Gray PC, Bertolette D, Cuttitta F, Salomon D.
    Semin Cancer Biol; 2014 Dec 27; 29():51-8. PubMed ID: 25153355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.